Johannes von Baumbach

Age 20; estimated US$6.6bn. Family pharmaceutical ownership. Boehringer Ingelheim began in 1885 and remains privately owned by its founding family. His fortune therefore reflects a share of a long-established business rather than a new venture launched in his twenties. The image is an original industry illustration, not a portrait.